Method of measuring substance in sample using a redox reaction

• US 20020025546A1
• Filed: 09/05/2001
• Published: 02/28/2002
• Est. Priority Date: 11/17/1998
• Status: Active Grant

• Current Assignee: Kyoto Daiichi Kagaku Company Limited
• Original Assignee: Kyoto Daiichi Kagaku Company Limited
• Inventors: Yonehara, Satoshi, Komori, Tsuguki
• Granted Patent: US 6,514,720 B2
• Time in Patent Office: Days
• US Class Current: 435/28
• CPC Class Codes: C12Q 1/28 involving peroxidase
• CPC Class Codes: G01N 33/725 using peroxidative activity

Abstract

A highly reliable method of measuring an analyte in a sample using a redox reaction. In this method, a tetrazolium compound is added to a sample prior to the redox reaction so as to eliminate the influence of any reducing substance in the sample, then a reducing substance or an oxidizing substance derived from the analyte is formed, the quantity of the formed substance derived from the analyte is measured by the redox reaction, and the quantity of the analyte is determined from the quantity of the formed substance derived from the analyte. As the tetrazolium compound, for example, 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt can be used.

Claims

1. A method of measuring an analyte in a sample using a redox reaction, comprising:

adding a tetrazolium compound to a sample prior to the redox reaction so as to eliminate the influence of any reducing substance contained in the sample;

then

forming a reducing substance or an oxidizing substance derived from the analyte;

measuring the quantity of the formed substance derived from the analyte by the redox reaction; and

determining the quantity of the analyte from the quantity of the formed substance derived from the analyte.

2. The method according to claim 1, wherein the tetrazolium compound has cyclic substituted groups in at least two positions of its tetrazole ring.

3. The method according to claim 2, wherein at least two of the cyclic substituted groups have benzene rings.

4. The method according to claim 1, wherein the tetrazolium compound has cyclic substituted groups in at least three positions of its tetrazole ring, and at least two of the cyclic substituted groups have benzene rings.

5. The method according to claim 2, wherein at least one of the cyclic substituted groups has an electron attractive functional group.

6. The method according to claim 5, wherein the electron attractive functional group is at least one functional group selected from the group consisting of halogen atoms and ether, ester, carboxyl, acyl, nitroso, nitro, hydroxyl, and sulfo groups.

7. The method according to claim 1, wherein the tetrazolium compound has benzene rings at positions 2 and 3 of its tetrazole ring, and at least one of the benzene rings has at least one functional group selected from the group consisting of halogen atoms and carboxyl, nitro, hydroxyl, sulfo, methoxy, and ethoxy groups.

8. The method according to claim 1, wherein the tetrazolium compound is at least one compound selected from the group consisting of 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt, 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium salt, 3,3′

-(1,1′

-biphenyl-4,4′

-diyl)-bis(2,5-diphenyl)-2H-tetrazolium salt, 3,3′

-[3,3′

-dimethoxy-(1,1′

-biphenyl)-4,4′

-diyl]-bis[2-(4-nitrophenyl)-5-phenyl-2H-tetrazolium salt], 2,3-diphenyl-5-(4-chlorophenyl)tetrazolium salt, 2,5-diphenyl-3-(p-diphenyl)tetrazolium salt, 2,3-diphenyl-5-p-diphenyl)tetrazolium salt, 2,5-diphenyl-3-(4-styrylphenyl)tetrazolium salt, 2,5-diphenyl-3-(m-tolyl)tetrazolium salt, and 2,5-diphenyl-3-(p-tolyl)tetrazolium salt.

9. The method according to claim 1, wherein the tetrazolium compound is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt.

10. The method according to claim 1, wherein the tetrazolium compound is added so that its concentration falls in a range of 0.001 to 100 μ

mol per 1 μ

l of the sample.

11. The method according to claim 1, wherein the sample is whole blood, and the tetrazolium compound is added so that its concentration falls in a range of 0.001 to 10 μ

mol per 1 μ

l of the whole blood.

12. The method according to claim 9, wherein the sample is whole blood, and 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt is added so that its concentration falls in a range of 0.001 to 0.4 μ

mol per 1 μ

l of the whole blood.

13. The method according to claim 1, wherein the oxidizing substance derived from the analyte is hydrogen peroxide, and the quantity of the hydrogen peroxide is measured by the redox reaction.

14. The method according to claim 13, wherein the quantity of the hydrogen peroxide is measured using a peroxidase and a substrate that develops color by oxidation.

15. The method according to claim 14, wherein the substrate is N-(carboxymethylaminocarbonyl)-4,4′

-bis(dimethylamino)diphenylamine sodium.

16. The method according to claim 1, wherein the analyte is a component in erythrocytes.

17. The method according to claim 13, wherein the analyte is a glycated protein in erythrocytes, and the hydrogen peroxide is formed by decomposing a sugar portion of the glycated protein by oxidation with fructosyl amino acid oxidase.

18. The method according to claim 1, wherein a molecular weight of the reducing substance in the sample is at least 10,000.

19. The method according to claim 1, wherein the reducing substance in the sample is a protein.

20. The method according to claim 1, wherein the reducing substance in the sample is hemoglobin.